Skip to main content

Table 1 Glycated hemoglobin, neuropathy symptom and disability scores, and autonomic nervous system assessment among diabetic neuropathy patients (group I), diabetic patients without neuropathy (group II) and healthy control (group III)

From: Sleep disturbances in diabetic peripheral neuropathy patients: a clinical and polysomnographic study

  Group I Group II Group III ANOVA
Range Mean ± SD Range Mean ± SD Range Mean ± SD f value p value
HBA1c (%) 6.7–11.5 8.33 ± 1.48 6.8–8.5 7.57 ± 0.53 5.5–6.3 5.90 ± 0.26 16.18 < 0.0001*
NSS 5–9 7.1 ± 1.48 1–4 2 ± 1.05 1–3 1.6 ± 0.69 92.73 < 0.0001*
NDS 6–10 8.05 ± 1.5 1–4 2.1 ± 0.99 1–2 1.5 ± 0.52 133.6 < 0.0001*
PSH 10–40 23.3 ± 11.2 5–13 8.8 ± 2.48 5–10 6.7 ± 1.49 18.46 < 0.0001*
Postural tachycardia 13–39 23.8 ± 8.03 13–26 14.3 ± 4.5 11–21 15.3 ± 2.98 6.31 0.0044*
HRDB 5–16 10.7 ± 3.4 9–18 13.1 ± 2.76 9–18 13.9 ± 2.88 4.08 0.025*
HRV 1.1–1.3 1.25 ± 0.06 1.3–1.4 1.29 ± 0.04 1.2–1.4 1.29 ± 0.04 3.40 0.51
  1. HRDB heart rate response to deep breath, HRV heart rate response to Valsalva, NDS neuropathy disability score, NSS neuropathy symptom score, PSH postural systolic hypotension
  2. *Significant